Curcuma longa L. extract and residue prevent Alzheimer’s disease in mice by regulating microglia and TLR4/NF- κ B signaling pathway
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Zhihui Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Materia Medica, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R. China. Hauptthemen laut MEDLINE: Alzheimer Disease, Toll-Like Receptor 4, Plant Extracts, Microglia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Industrial Technology Foundation Public Service Platform Project of 2022.
Themen: Demenz
Abstract (Originalsprache)
Background
Curcuma longa L. (CL) is renowned for its various health benefits and has shown potential in alleviating Alzheimer’s disease (AD). The post-aqueous extraction residues (CLR) may retain valuable nutritional components. The research aimed to explore their chemical composition and neuroprotective mechanism against Aβ1-42-induced AD mice.
Methods
We employed UPLC-Q-Exactive/MS to characterize the chemical constituents of CL and CLR. An HPLC method was developed to quantify three predominant curcuminoids. To investigate their neuroprotective effects against Aβ1-42-induced AD mice, we assessed cognitive function using the Morris water maze and evaluated neuronal damage through histopathological examination. Molecular mechanisms were explored using immunofluorescence, ELISA, and qRT-PCR assays.
Results
The study unveiled 47 and 36 compounds in CL and CLR, respectively, and eight significant differential components. HPLC analysis revealed that CLR contained substantial curcuminoids. In Aβ1-42-induced AD mice, CL and CLR improved spatial learning and memory ability, ameliorated pathological alterations in the hippocampal region, and regulated overactivated microglia. Moreover, CL and CLR inhibited the TLR4/NF-κB inflammatory pathway.
Conclusion
CL and CLR exhibit the anti-AD effect by regulating microglia and suppressing the TLR4/NF-κB signaling pathway, which provides a scientific basis for future nutraceutical and pharmaceutical development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Materia Medica, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R. China.
- Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Formula Granule, Guangdong Yifang Pharmaceutical Co., Ltd., Foshan, Guangdong 528244, P.R. China.
ORCID-Profile: Yu Zeng
Förderung
- Industrial Technology Foundation Public Service Platform Project of 2022
Zitieren
APA
Xu, Z., Li, J., Liu, X., Liu, L., Lin, W., Sun, D., & Zeng, Y. (2025). Curcuma longa L. extract and residue prevent Alzheimer’s disease in mice by regulating microglia and TLR4/NF- κ B signaling pathway. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf034
Vancouver
Xu Z, Li J, Liu X, Liu L, Lin W, Sun D, et al. Curcuma longa L. extract and residue prevent Alzheimer’s disease in mice by regulating microglia and TLR4/NF- κ B signaling pathway. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf034
BibTeX
@article{Xu2025,
author = {Xu, Zhihui and Li, Jianlin and Liu, Xiaotong and Liu, Liaoyuan and Lin, Weixiong and Sun, Dongmei and Zeng, Yu},
title = {Curcuma longa L. extract and residue prevent Alzheimer’s disease in mice by regulating microglia and TLR4/NF- κ B signaling pathway},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf034}
}
EUVIMED